FDA Adverse Event Injury Summary report: N

REPLY

MDR report key: 3830096 · Received May 23, 2014

Report

Report Number
1000165971-2014-00298
Event Type
Injury
Date Received
May 23, 2014
Date of Event
April 8, 2014
Report Date
April 22, 2014
Manufacturer
SORIN GROUP ITALIA S.R.L. - CRM FACILITY
Product Code
NVZ
PMA / PMN Number
PP950029
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

INVESTIGATION RESULTS OF THE RETURNED UNIT CONFIRMED THAT THE END OF LIFE WAS REACHED; HOWEVER CURRENT CONSUMPTION OF THE ELECTRONIC MODULE WAS NORMAL.

Description of Event or Problem · 1

REPORTEDLY, DURING THE FOLLOW-UP OF THE SUBJECT PACEMAKER PERFORMED ON (B)(6) 2014, END OF LIFE (EOL) WAS REACHED. THE DEVICE WAS EXPLANTED AND RETURNED FOR ANALYSIS. IT WAS REPORTED ALSO THAT DURING PREVIOUS FOLLOW-UP PERFORMED ON (B)(6) 2013, THE BATTERY IMPEDANCE WAS AT 2.8 KOHM AND IT WAS DISPLAYED A TIME TO ELECTIVE REPLACEMENT INDICATOR (ERI) OF 13 MONTHS.

Description of Event or Problem · 1

REPORTEDLY, DURING THE FOLLOW-UP OF THE SUBJECT PACEMAKER PERFORMED ON(B)(6) 2014, END OF LIFE (EOL) WAS REACHED. THE DEVICE WAS EXPLANTED AND RETURNED FOR ANALYSIS. IT WAS REPORTED ALSO THAT DURING PREVIOUS FOLLOW-UP PERFORMED ON (B)(6) 2013, THE BATTERY IMPEDANCE WAS AT 2.8 KOHM AND IT WAS DISPLAYED A TIME TO ELECTIVE REPLACEMENT INDICATOR (ERI) OF 13 MONTHS.

Description of Event or Problem · 1

REPORTEDLY, DURING THE FOLLOW-UP OF THE SUBJECT PACEMAKER PERFORMED ON (B)(6) 2014, END OF LIFE (EOL) WAS REACHED. THE DEVICE WAS EXPLANTED AND RETURNED FOR ANALYSIS. IT WAS REPORTED ALSO THAT DURING PREVIOUS FOLLOW-UP PERFORMED ON (B)(6) 2013, THE BATTERY IMPEDANCE WAS AT 2.8 KOHM AND IT WAS DISPLAYED A TIME TO ELECTIVE REPLACEMENT INDICATOR (ERI) OF 13 MONTHS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
308514 REPLY PULSE GENERATOR, PERMANENT, IMPLANTABLE NVZ SORIN GROUP ITALIA S.R.L. - CRM FACILITY ESPRIT DR 2420

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R